Surge in Put Option Activity for Sun Pharmaceutical with 4,629 Contracts at Rs 1600 Strike

Sun Pharmaceutical Industries Ltd has emerged as one of the most active stocks in the options market today, particularly in the put options segment. The underlying stock, SUNPHARMA, is currently valued at Rs 1617.6, which is approximately 3.91% away from its 52-week low of Rs 1553.05.
Today, two significant put options were traded with expiry set for August 28, 2025. The first option, with a strike price of Rs 1620, saw 3,685 contracts traded, resulting in a turnover of Rs 168.18 lakhs and an open interest of 649 contracts. The second option, with a strike price of Rs 1600, recorded 4,629 contracts traded, generating a turnover of Rs 106.61 lakhs and an open interest of 1,125 contracts.

In terms of performance, SUNPHARMA has underperformed its sector by 0.98% and has experienced a trend reversal after four consecutive days of gains. The stock reached an intraday low of Rs 1610, reflecting a decline of 2.82%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.

Investor participation has also decreased, with a delivery volume of 14.12 lakhs on August 25, down 14.77% compared to the 5-day average. Despite these challenges, the stock remains liquid enough for trades sized at Rs 6.95 crore, given its market capitalization of Rs 3,87,085.00 crore in the pharmaceuticals and biotechnology sector.

In summary, Sun Pharmaceutical Industries Ltd is witnessing notable activity in its put options, reflecting current market dynamics and investor behavior.